CALCA and COVID-19: In a research paper published in Critical Care assessing the impact of immunomodulatory therapy on the kinetics of PCT and CRP in COVID-19 patients and their usefulness in early detection of secondary bacterial infections, it was shown that the value of these two inflammatory markers was significantly reduced in patients with immunomodulation.